Synthesis and action of mineralocorticoids in cardiovascular systems

盐皮质激素的合成及其在心血管系统中的作用

基本信息

  • 批准号:
    16570122
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Aldosterone is a most potent mineralocorticoid which regulates water and electrolyte metabolisms in mammals. This steroid hormone is synthesized and secreted from the zona glomerulosa of adrenal cortex, and acts through mineralocorticoid receptor (MR) in the epithelial cells transport water and electrolytes. Recently, however, evidence that aldosterone is synthesized in the cardiovascular systems and acts in a paracrine manner through MR has been reported. It has been known that aldosterone is involved in cardiac hypertrophy and fibrosis and in homeostasis of vasculature. In this study, we examined molecular basis for synthesis and action of aldosterone in the cardiovascular systems. Examination of mRNA level of aldosterone synthase in aortas and hearts of normal rats showed that it was detectable but almost at its detection limit. mRNAs of factors responsible for aldosterone action were easily detectable. Next, we employed Dahl salt-sensitive rats fed on 8% NaCl-containing diets as an … More animal model for aldosterone-inducible heart failure. Salt-loading resulted in induction of aldosterone synthase mRNA frequently, while expression levels of the factors for aldosterone action mostly did not changed. Interestingly, expression of a newly cloned factor AZ-1, whose expression correlates with aldosterone synthesis and action, was enhanced in aortas and hearts significantly. Furthermore, we used another experimental animal model of cardiac hypertrophy and fibrosis by continuous administration (6 weeks) of aldosterone into normal rats fed on 1% NaCl-containing drinking water. The aldosterone administration caused hypertension with systolic blood pressure at 170 mmHg. Judging from histochemical analysis of the hearts they showed hypertrophy with accumulating collagenous fibrils. Immunohistochemical examination with anti-AZ-1 antibody revealed that AZ-1 became detectable in capillaries and interstitial spaces between cardiac muscle cells. Aldosterone caused cardiac hypertrophy and fibrosis through MR and induced expression of extracellular matrix proteins including AZ-1. Less
醛固酮是一种调节哺乳动物水电解质代谢的强有力的盐皮质激素。这种类固醇激素由肾上腺皮质的肾小球合成和分泌,并通过上皮细胞中的盐皮质激素受体(MR)转运水和电解质发挥作用。然而,最近有证据表明,醛固酮是在心血管系统中合成的,并通过MR以旁分泌方式发挥作用。已知醛固酮参与心脏肥大和纤维化以及血管系统的稳态。在这项研究中,我们研究了醛固酮在心血管系统中的合成和作用的分子基础。对正常大鼠心脏和心脏醛固酮合成酶mRNA水平的检测表明,它是可检测的,但几乎在其检测限。负责醛固酮作用的因子的mRNA很容易检测。接下来,我们采用了Dahl盐敏感大鼠,喂食含8% NaCl的饮食, ...更多信息 用于醛固酮诱导的心力衰竭的动物模型。盐负荷导致醛固酮合成酶mRNA的诱导频繁,而醛固酮作用因子的表达水平大多没有改变。有趣的是,新克隆的因子AZ-1的表达在主动脉和心脏中显着增强,该因子的表达与醛固酮的合成和作用相关。此外,我们使用了另一种心脏肥大和纤维化的实验动物模型,通过连续给药(6周)醛固酮到正常大鼠喂食含1%NaCl的饮用水。醛固酮给药引起高血压,收缩压为170 mmHg。从心脏的组织化学分析来看,它们显示出肥厚和胶原纤维积聚。用抗AZ-1抗体的免疫组织化学检查显示AZ-1在毛细血管和心肌细胞间质中变得可检测。醛固酮通过MR引起心肌肥厚和纤维化,并诱导细胞外基质蛋白(包括AZ-1)的表达。少

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of AZ-1 protein : a member of proteolytically inactive preprocathepsin B-related proteins with cysteine-rich sequence
AZ-1 蛋白的表征:具有富含半胱氨酸序列的蛋白水解失活前组织蛋白酶 B 相关蛋白的成员
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    向井邦晃;他
  • 通讯作者:
副腎皮質の眉分化制御因子の同定
肾上腺皮质眉毛分化调节因素的鉴定
Possible participation of outer mitochondrial membrane cytochrome b5 in steroidogenesis in zona glomerulosa of rat adrenal cortex
线粒体外膜细胞色素b5可能参与大鼠肾上腺皮质球状带类固醇生成
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mitani;F.
  • 通讯作者:
    F.
副腎皮質のステロイドホルモン産生系におけるアスコルビン酸の役割
抗坏血酸在肾上腺皮质类固醇激素产生系统中的作用
Characterization of AZ-1 protein : a member of proteolytica 11y inactive preprocathepsin B-related proteins with cyste ine-rich sequences.
AZ-1 蛋白的表征:蛋白水解酶 11y 无活性前组织蛋白酶 B 相关蛋白的成员,具有富含半胱氨酸的序列。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mitani;F.;李 丹;向井邦晃
  • 通讯作者:
    向井邦晃
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUKAI Kuniaki其他文献

MUKAI Kuniaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUKAI Kuniaki', 18)}}的其他基金

Inhibitory action of a matricellular protein AZ-1 on vascular endothelium growth factor-receptor
基质细胞蛋白AZ-1对血管内皮生长因子受体的抑制作用
  • 批准号:
    21510229
  • 财政年份:
    2009
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel secretory protein identified from an adrenocortical precursor cell-line
从肾上腺皮质前体细胞系中鉴定出一种新型分泌蛋白
  • 批准号:
    13680724
  • 财政年份:
    2001
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulatory mechanisms for differentiation of adrenocortical cells
肾上腺皮质细胞分化的调控机制
  • 批准号:
    10680621
  • 财政年份:
    1998
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Processivity and Catalytic Mechanism of Aldosterone Synthase
醛固酮合酶的持续合成能力和催化机制
  • 批准号:
    10600520
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Aldosterone/mineralocorticoid receptor responses to biologic sex and salt intake: Role of Lysine Specific Demethylase 1 (LSD1)
醛固酮/盐皮质激素受体对生物性别和盐摄入量的反应:赖氨酸特异性脱甲基酶 1 (LSD1) 的作用
  • 批准号:
    10930190
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors
OSA 中的冠状动脉功能障碍:盐皮质激素受体的作用
  • 批准号:
    10734658
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Origins of sex differences in the mechanisms of obesity-associated hypertension
肥胖相关高血压机制中性别差异的起源
  • 批准号:
    10678441
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
探索新型阻断剂和联合用药在人源化小鼠中缓解 HIV
  • 批准号:
    10714365
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension
盐皮质激素受体、冠状动脉微血管功能和高血压患者的心脏效率
  • 批准号:
    10586784
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Aldosterone blockade for Health Improvement Evaluation in End-stage kidney disease: Extension
醛固酮阻断用于终末期肾病健康改善评估:延伸
  • 批准号:
    461992
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Operating Grants
Cardiac Perfusion, Structure, and Function across the Primary Aldosteronism Spectrum
原发性醛固酮增多症谱系的心脏灌注、结构和功能
  • 批准号:
    10448000
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
Role of Renin-Angiotensin-Aldosterone System during sarcoidosis granuloma formation
肾素-血管紧张素-醛固酮系统在结节病肉芽肿形成过程中的作用
  • 批准号:
    10591934
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy
盐皮质激素受体拮抗肌营养不良炎症的机制
  • 批准号:
    10542800
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了